Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Bibliographic Details
Main Authors: Sakai, Ryoko, Cho, Soo-Kyung, Nanki, Toshihiro, Watanabe, Kaori, Yamazaki, Hayato, Tanaka, Michi, Koike, Ryuji, Tanaka, Yoshiya, Saito, Kazuyoshi, Hirata, Shintaro, Amano, Koichi, Nagasawa, Hayato, Sumida, Takayuki, Hayashi, Taichi, Sugihara, Takahiko, Dobashi, Hiroaki, Yasuda, Shinsuke, Sawada, Tetsuji, Ezawa, Kazuhiko, Ueda, Atsuhisa, Fujii, Takao, Migita, Kiyoshi, Miyasaka, Nobuyuki, Harigai, Masayoshi
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384380/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384380/

Similar Items